Global Genome-Wide DNA Methylation Analysis Service Supply, Demand and Key Producers, 2026-2032
The global Genome-Wide DNA Methylation Analysis Service market size is expected to reach $ 536 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Genome-Wide DNA Methylation Analysis Service refers to a specialized scientific service that provides comprehensive profiling of DNA methylation patterns across an organism’s entire genome. This service leverages advanced molecular and computational techniques to identify, quantify, and interpret methylated cytosine residues—primarily in CpG dinucleotides—on a global scale, rather than focusing on individual genes or regions. By employing methods such as bisulfite sequencing (whole-genome bisulfite sequencing, WGBS), high-density methylation arrays, or single-molecule sequencing (which directly detects methyl groups without chemical conversion), the service generates detailed maps of epigenetic modifications that influence gene expression, chromatin structure, and cellular function.
RRBS offers a lower-data-volume approach by concentrating sequencing on CpG-rich genomic regions
Pharmaceutical and biotechnology users increasingly require methylation analysis for biomarker discovery disease stratification and translational research
Competition is shaped by sequencing depth sample flexibility bioinformatics capability turnaround time and integration of multiple methylation technologies
Market Trends
The Genome-Wide DNA Methylation Analysis Service market is moving from a bisulfite-sequencing-centered structure toward a broader portfolio of methylome technologies. WGBS remains important where researchers require comprehensive genome coverage and single-base methylation information, while RRBS continues to serve projects that prioritize CpG-rich regulatory regions and cost efficiency. At the same time, enzymatic conversion methods are gaining attention because they can reduce DNA damage associated with conventional bisulfite treatment and improve library quality for limited or degraded samples. Long-read sequencing is expanding the analytical scope by enabling methylation detection together with haplotype, structural-variant and repetitive-region information, while methylation arrays continue to provide standardized, scalable profiling for human cohort studies. Service providers are therefore shifting from single-assay offerings toward multi-technology portfolios in which customers select methods according to sample type, genome coverage, sequencing depth, throughput and downstream analytical objectives. Bioinformatics is becoming equally important, with greater demand for DMR analysis, pathway interpretation, cell-type-aware analysis and integration of methylation data with transcriptomic and genomic datasets.
Value Chain Analysis
The upstream value chain of Genome-Wide DNA Methylation Analysis Service includes sequencing instruments, methylation-conversion reagents, library-preparation kits, microarrays, flow cells, reference standards, laboratory automation, cloud infrastructure and bioinformatics software. Sequencing platforms and consumables account for an important part of laboratory operating costs, while conversion efficiency, library complexity and sequencing quality directly influence downstream data value. The development of enzymatic methylation methods and long-read platforms is broadening the upstream technology base beyond traditional bisulfite chemistry.
The midstream layer consists of service providers responsible for sample handling, assay selection, library construction, sequencing or array processing, quality control, methylation calling and biological interpretation. Value creation increasingly shifts toward workflow integration and bioinformatics rather than raw sequencing alone. Downstream users include Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical Diagnostics Labs and Other organizations conducting epigenetic research. Higher-value projects typically require customized experimental design, cohort-level statistics, biomarker analysis, multi-omics integration and technical consulting, while standardized high-throughput projects rely more heavily on automation, sequencing scale and efficient data processing.
Segment Insights
Whole Genome Bisulfite Sequencing (WGBS) represents the most comprehensive sequencing-based segment within Genome-Wide DNA Methylation Analysis Service. By interrogating methylated cytosines across the genome at single-base resolution, WGBS is particularly suitable for discovery-oriented research, non-CpG methylation analysis and projects requiring unbiased methylome coverage. Its principal trade-off is higher sequencing and computational demand, making experimental design and depth selection important to project economics. Service providers with large-scale sequencing capacity and integrated bioinformatics are well positioned to support cohort-scale WGBS projects.
Reduced Representation Bisulfite Sequencing (RRBS) concentrates sequencing on CpG-rich regions and therefore reduces data requirements relative to WGBS while retaining high-resolution information in many promoters and regulatory regions. It is particularly useful for comparative studies involving larger sample numbers where full-genome sequencing depth is not essential. The Other segment provides technological diversification through enzymatic methylation sequencing, methylation arrays and long-read methylation analysis. These methods address different limitations of conventional bisulfite workflows and expand the market toward low-input samples, standardized cohort profiling and direct detection of methylation on long DNA molecules. The three segments therefore represent complementary approaches rather than a simple hierarchy of technical performance.
Downstream Market Opportunities
Academic and Research Institutions remain a foundational user group for Genome-Wide DNA Methylation Analysis Service because epigenetics is deeply integrated into cancer biology, developmental research, aging, neuroscience and environmental genomics. Pharmaceutical and Biotechnology Companies offer higher-value opportunities where methylation data support biomarker discovery, patient stratification, drug-response analysis and translational development. Clinical Diagnostics Labs represent a more demanding but potentially important application as validated methylation signatures are translated into molecular diagnostic and disease-classification workflows. Other users include agricultural genomics, reproductive research and specialized translational laboratories. Across applications, opportunities increasingly favor service providers capable of supporting projects from experimental design through sequencing, bioinformatics and biological interpretation rather than delivering sequence data alone.
Europe and Asia form additional major centers of technical capability. European participants such as Hologic Diagenode and CeGaT GmbH provide methylation sequencing and related epigenomics services, while Asia has a broad sequencing-service base represented by BGI Genomics, Novogene, Macrogen, Inc. and LC-Bio. Japan adds specialized service capability through Rhelixa, Inc., RIKEN GENESIS Co., Ltd. and bitBiome, Inc., covering WGBS, methylation arrays and long-read methylation analysis. Regional differentiation is increasingly determined by sequencing scale, access to advanced platforms, bioinformatics expertise, regulatory environment and proximity to academic, pharmaceutical and clinical research customers.
This report is a detailed and comprehensive analysis of the world market for Genome-Wide DNA Methylation Analysis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome-Wide DNA Methylation Analysis Service that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome-Wide DNA Methylation Analysis Service market
2. What is the demand of the global Genome-Wide DNA Methylation Analysis Service market?
3. What is the year over year growth of the global Genome-Wide DNA Methylation Analysis Service market?
4. What is the total value of the global Genome-Wide DNA Methylation Analysis Service market?
5. Who are the Major Players in the global Genome-Wide DNA Methylation Analysis Service market?
6. What are the growth factors driving the market demand?
Genome-Wide DNA Methylation Analysis Service refers to a specialized scientific service that provides comprehensive profiling of DNA methylation patterns across an organism’s entire genome. This service leverages advanced molecular and computational techniques to identify, quantify, and interpret methylated cytosine residues—primarily in CpG dinucleotides—on a global scale, rather than focusing on individual genes or regions. By employing methods such as bisulfite sequencing (whole-genome bisulfite sequencing, WGBS), high-density methylation arrays, or single-molecule sequencing (which directly detects methyl groups without chemical conversion), the service generates detailed maps of epigenetic modifications that influence gene expression, chromatin structure, and cellular function.
Key Findings
WGBS provides the broadest methylome coverage and remains a core technology for comprehensive genome-wide methylation profilingRRBS offers a lower-data-volume approach by concentrating sequencing on CpG-rich genomic regions
Pharmaceutical and biotechnology users increasingly require methylation analysis for biomarker discovery disease stratification and translational research
Competition is shaped by sequencing depth sample flexibility bioinformatics capability turnaround time and integration of multiple methylation technologies
Market Trends
The Genome-Wide DNA Methylation Analysis Service market is moving from a bisulfite-sequencing-centered structure toward a broader portfolio of methylome technologies. WGBS remains important where researchers require comprehensive genome coverage and single-base methylation information, while RRBS continues to serve projects that prioritize CpG-rich regulatory regions and cost efficiency. At the same time, enzymatic conversion methods are gaining attention because they can reduce DNA damage associated with conventional bisulfite treatment and improve library quality for limited or degraded samples. Long-read sequencing is expanding the analytical scope by enabling methylation detection together with haplotype, structural-variant and repetitive-region information, while methylation arrays continue to provide standardized, scalable profiling for human cohort studies. Service providers are therefore shifting from single-assay offerings toward multi-technology portfolios in which customers select methods according to sample type, genome coverage, sequencing depth, throughput and downstream analytical objectives. Bioinformatics is becoming equally important, with greater demand for DMR analysis, pathway interpretation, cell-type-aware analysis and integration of methylation data with transcriptomic and genomic datasets.
Market Dynamics
Drivers
Growth in Genome-Wide DNA Methylation Analysis Service is supported by expanding research into cancer, neurological disease, developmental biology, aging, immune regulation and other conditions in which epigenetic variation contributes to phenotype and disease progression. Academic and Research Institutions use genome-wide methylation data to investigate gene regulation and environmental effects, while Pharmaceutical and Biotechnology Companies increasingly apply methylome analysis to biomarker discovery, patient stratification, target validation and treatment-response studies. Falling sequencing costs, improved library-preparation workflows and greater availability of high-throughput sequencing systems also make methylation profiling accessible to a wider set of research projects. Another important driver is the growing use of multi-omics approaches, in which DNA methylation is analyzed alongside genomic, transcriptomic and proteomic information to provide a more complete view of biological mechanisms.Restraints
The main restraints are sequencing cost, analytical complexity and sensitivity to sample quality. WGBS can require substantial sequencing depth because most reads do not originate from methylated regulatory regions specifically, which increases data generation, storage and computational requirements. Conventional bisulfite conversion can fragment DNA and reduce sequence complexity, creating additional challenges for low-input or degraded samples. Cross-study comparability may also be affected by differences in library preparation, sequencing depth, reference genomes, normalization methods and methylation-calling pipelines. For clinical-oriented projects, laboratory validation, reproducibility, quality-management requirements and interpretation standards can further raise the cost and time required to translate research assays into routine diagnostic workflows.Opportunities
The market offers meaningful opportunities in low-input samples, liquid biopsy, longitudinal disease monitoring and large-scale cohort studies. Improved enzymatic conversion methods and optimized library preparation may expand analysis of cfDNA, archived tissues and other limited-material samples. Long-read methylation analysis creates opportunities to study allele-specific methylation, repetitive regions and structural genomic contexts that are difficult to resolve with conventional short-read sequencing. Another opportunity lies in integrated multi-omics services combining DNA methylation with RNA sequencing, whole-genome sequencing or chromatin analysis within one analytical workflow. Pharmaceutical and Biotechnology Companies also create potential for higher-value projects because drug-development programs increasingly require biomarker qualification, mechanistic interpretation and longitudinal data integration rather than sequencing alone. Service providers with flexible technology portfolios and strong bioinformatics capabilities can therefore move toward higher-value analytical and translational services.Challenges
The industry faces persistent challenges in standardization, interpretation and clinical translation. Genome-wide methylation datasets contain large numbers of potentially variable sites, but statistical significance does not automatically indicate biological or clinical relevance. Differences in tissue composition, age, environmental exposure and disease state can create confounding effects, making study design and bioinformatics expertise critical. Service providers must also maintain compatibility with rapidly evolving sequencing platforms and library-preparation technologies while controlling batch effects across long-running projects. In Clinical Diagnostics Labs, assay validation and reproducibility requirements are substantially higher than in exploratory research, and clinically meaningful methylation signatures must be demonstrated across independent populations. Managing sensitive genomic data, cross-border data transfer and privacy requirements adds another layer of operational complexity for global service providers.Value Chain Analysis
The upstream value chain of Genome-Wide DNA Methylation Analysis Service includes sequencing instruments, methylation-conversion reagents, library-preparation kits, microarrays, flow cells, reference standards, laboratory automation, cloud infrastructure and bioinformatics software. Sequencing platforms and consumables account for an important part of laboratory operating costs, while conversion efficiency, library complexity and sequencing quality directly influence downstream data value. The development of enzymatic methylation methods and long-read platforms is broadening the upstream technology base beyond traditional bisulfite chemistry.
The midstream layer consists of service providers responsible for sample handling, assay selection, library construction, sequencing or array processing, quality control, methylation calling and biological interpretation. Value creation increasingly shifts toward workflow integration and bioinformatics rather than raw sequencing alone. Downstream users include Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical Diagnostics Labs and Other organizations conducting epigenetic research. Higher-value projects typically require customized experimental design, cohort-level statistics, biomarker analysis, multi-omics integration and technical consulting, while standardized high-throughput projects rely more heavily on automation, sequencing scale and efficient data processing.
Segment Insights
Whole Genome Bisulfite Sequencing (WGBS) represents the most comprehensive sequencing-based segment within Genome-Wide DNA Methylation Analysis Service. By interrogating methylated cytosines across the genome at single-base resolution, WGBS is particularly suitable for discovery-oriented research, non-CpG methylation analysis and projects requiring unbiased methylome coverage. Its principal trade-off is higher sequencing and computational demand, making experimental design and depth selection important to project economics. Service providers with large-scale sequencing capacity and integrated bioinformatics are well positioned to support cohort-scale WGBS projects.
Reduced Representation Bisulfite Sequencing (RRBS) concentrates sequencing on CpG-rich regions and therefore reduces data requirements relative to WGBS while retaining high-resolution information in many promoters and regulatory regions. It is particularly useful for comparative studies involving larger sample numbers where full-genome sequencing depth is not essential. The Other segment provides technological diversification through enzymatic methylation sequencing, methylation arrays and long-read methylation analysis. These methods address different limitations of conventional bisulfite workflows and expand the market toward low-input samples, standardized cohort profiling and direct detection of methylation on long DNA molecules. The three segments therefore represent complementary approaches rather than a simple hierarchy of technical performance.
Downstream Market Opportunities
Academic and Research Institutions remain a foundational user group for Genome-Wide DNA Methylation Analysis Service because epigenetics is deeply integrated into cancer biology, developmental research, aging, neuroscience and environmental genomics. Pharmaceutical and Biotechnology Companies offer higher-value opportunities where methylation data support biomarker discovery, patient stratification, drug-response analysis and translational development. Clinical Diagnostics Labs represent a more demanding but potentially important application as validated methylation signatures are translated into molecular diagnostic and disease-classification workflows. Other users include agricultural genomics, reproductive research and specialized translational laboratories. Across applications, opportunities increasingly favor service providers capable of supporting projects from experimental design through sequencing, bioinformatics and biological interpretation rather than delivering sequence data alone.
Regional Insights
North America has a mature ecosystem for Genome-Wide DNA Methylation Analysis Service, supported by extensive biomedical research, biotechnology investment and established sequencing-service infrastructure. Azenta Life Sciences (GENEWIZ), Zymo Research, Active Motif, Psomagen, Inc., EpiGentek and CD Genomics participate across sequencing, epigenetics and analytical service models. Customer demand ranges from academic discovery projects to pharmaceutical biomarker programs, creating opportunities for both standardized sequencing and customized analytical services. The region also benefits from broad adoption of multi-omics research and strong demand for high-throughput molecular profiling.Europe and Asia form additional major centers of technical capability. European participants such as Hologic Diagenode and CeGaT GmbH provide methylation sequencing and related epigenomics services, while Asia has a broad sequencing-service base represented by BGI Genomics, Novogene, Macrogen, Inc. and LC-Bio. Japan adds specialized service capability through Rhelixa, Inc., RIKEN GENESIS Co., Ltd. and bitBiome, Inc., covering WGBS, methylation arrays and long-read methylation analysis. Regional differentiation is increasingly determined by sequencing scale, access to advanced platforms, bioinformatics expertise, regulatory environment and proximity to academic, pharmaceutical and clinical research customers.
Competitive Landscape Analysis
The competitive landscape of Genome-Wide DNA Methylation Analysis Service combines large sequencing service organizations, specialized epigenetics companies and technology-focused regional laboratories. Azenta Life Sciences (GENEWIZ), BGI Genomics, Novogene and Macrogen, Inc. compete from broad sequencing-service platforms that can integrate methylation analysis with other genomic and transcriptomic workflows. Zymo Research, Hologic Diagenode, Active Motif and EpiGentek have stronger specialization in epigenetics technologies and methylation-related workflows, while CeGaT GmbH and Psomagen, Inc. combine sequencing infrastructure with research and translational analytical services. CD Genomics offers multiple methylation technology routes, while LC-Bio participates through genome-wide bisulfite sequencing and associated bioinformatics. In Japan, Rhelixa, Inc. provides WGBS-oriented epigenomic services, RIKEN GENESIS Co., Ltd. contributes array-based methylation analysis, and bitBiome, Inc. provides a differentiated long-read methylation route. Competitive advantage is increasingly determined by technology breadth, sequencing quality, sample-type flexibility, bioinformatics depth, turnaround time, project customization and the ability to integrate methylation analysis with broader multi-omics workflows rather than by sequencing capacity alone.Report Scope
This report studies the global Genome-Wide DNA Methylation Analysis Service demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Genome-Wide DNA Methylation Analysis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome-Wide DNA Methylation Analysis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Genome-Wide DNA Methylation Analysis Service total market, 2021-2032, (USD Million)
- Global Genome-Wide DNA Methylation Analysis Service total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Genome-Wide DNA Methylation Analysis Service total market, key domestic companies, and share, (USD Million)
- Global Genome-Wide DNA Methylation Analysis Service revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Genome-Wide DNA Methylation Analysis Service total market by Type, CAGR, 2021-2032, (USD Million)
- Global Genome-Wide DNA Methylation Analysis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Genome-Wide DNA Methylation Analysis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Genome-Wide DNA Methylation Analysis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Genome-Wide DNA Methylation Analysis Service Market, Segmentation by Type:
- Whole Genome Bisulfite Sequencing (WGBS)
- Reduced Representation Bisulfite Sequencing (RRBS)
- Other
Global Genome-Wide DNA Methylation Analysis Service Market, Segmentation by Sample Variety:
- Tissue Samples
- Blood & Body Fluid Samples
- Cell & Cell Line Samples
- Other
Global Genome-Wide DNA Methylation Analysis Service Market, Segmentation by Project Sample Number:
- Small-Scale: ≤10 Samples
- Medium-Scale: 11–50 Samples
- Large-Scale: 51–200 Samples
- High-Throughput: >200 Samples
Global Genome-Wide DNA Methylation Analysis Service Market, Segmentation by Application:
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostics Labs
- Others
Companies Profiled:
- Azenta Life Sciences (GENEWIZ)
- BGI Genomics
- Novogene
- Macrogen, Inc.
- Zymo Research
- Hologic Diagenode
- CeGaT GmbH
- Active Motif
- Psomagen, Inc.
- EpiGentek
- CD Genomics
- LC-Bio
- Rhelixa, Inc.
- RIKEN GENESIS Co., Ltd.
- bitBiome, Inc.
Key Questions Answered
1. How big is the global Genome-Wide DNA Methylation Analysis Service market?2. What is the demand of the global Genome-Wide DNA Methylation Analysis Service market?
3. What is the year over year growth of the global Genome-Wide DNA Methylation Analysis Service market?
4. What is the total value of the global Genome-Wide DNA Methylation Analysis Service market?
5. Who are the Major Players in the global Genome-Wide DNA Methylation Analysis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genome-Wide DNA Methylation Analysis Service Introduction
1.2 World Genome-Wide DNA Methylation Analysis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Genome-Wide DNA Methylation Analysis Service Total Market by Region (by Headquarter Location)
1.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.3 China Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.4 Europe Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.5 Japan Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.8 India Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome-Wide DNA Methylation Analysis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.2 World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region
2.2.1 World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region (2021-2026)
2.2.2 World Genome-Wide DNA Methylation Analysis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.4 China Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.5 Europe Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.6 Japan Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.7 South Korea Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.8 ASEAN Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.9 India Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
3 WORLD GENOME-WIDE DNA METHYLATION ANALYSIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Genome-Wide DNA Methylation Analysis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Genome-Wide DNA Methylation Analysis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Genome-Wide DNA Methylation Analysis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Genome-Wide DNA Methylation Analysis Service in 2025
3.3 Genome-Wide DNA Methylation Analysis Service Company Evaluation Quadrant
3.4 Genome-Wide DNA Methylation Analysis Service Market: Overall Company Footprint Analysis
3.4.1 Genome-Wide DNA Methylation Analysis Service Market: Region Footprint
3.4.2 Genome-Wide DNA Methylation Analysis Service Market: Company Product Type Footprint
3.4.3 Genome-Wide DNA Methylation Analysis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison
4.2.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Genome-Wide DNA Methylation Analysis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026)
4.4 China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Genome-Wide DNA Methylation Analysis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026)
4.5 Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole Genome Bisulfite Sequencing (WGBS)
5.2.2 Reduced Representation Bisulfite Sequencing (RRBS)
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2021-2026)
5.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2027-2032)
5.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE VARIETY
6.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Sample Variety: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample Variety
6.2.1 Tissue Samples
6.2.2 Blood & Body Fluid Samples
6.2.3 Cell & Cell Line Samples
6.2.4 Other
6.3 Market Segment by Sample Variety
6.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2021-2026)
6.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2027-2032)
6.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety (2027-2032)
7 MARKET ANALYSIS BY PROJECT SAMPLE NUMBER
7.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Project Sample Number: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Project Sample Number
7.2.1 Small-Scale: ≤10 Samples
7.2.2 Medium-Scale: 11–50 Samples
7.2.3 Large-Scale: 51–200 Samples
7.2.4 High-Throughput: >200 Samples
7.3 Market Segment by Project Sample Number
7.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2021-2026)
7.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2027-2032)
7.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic and Research Institutions
8.2.2 Pharmaceutical and Biotechnology Companies
8.2.3 Clinical Diagnostics Labs
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2021-2026)
8.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2027-2032)
8.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences (GENEWIZ)
9.1.1 Azenta Life Sciences (GENEWIZ) Details
9.1.2 Azenta Life Sciences (GENEWIZ) Major Business
9.1.3 Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Product and Services
9.1.4 Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences (GENEWIZ) Recent Developments/Updates
9.1.6 Azenta Life Sciences (GENEWIZ) Competitive Strengths & Weaknesses
9.2 BGI Genomics
9.2.1 BGI Genomics Details
9.2.2 BGI Genomics Major Business
9.2.3 BGI Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
9.2.4 BGI Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BGI Genomics Recent Developments/Updates
9.2.6 BGI Genomics Competitive Strengths & Weaknesses
9.3 Novogene
9.3.1 Novogene Details
9.3.2 Novogene Major Business
9.3.3 Novogene Genome-Wide DNA Methylation Analysis Service Product and Services
9.3.4 Novogene Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Novogene Recent Developments/Updates
9.3.6 Novogene Competitive Strengths & Weaknesses
9.4 Macrogen, Inc.
9.4.1 Macrogen, Inc. Details
9.4.2 Macrogen, Inc. Major Business
9.4.3 Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.4.4 Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Macrogen, Inc. Recent Developments/Updates
9.4.6 Macrogen, Inc. Competitive Strengths & Weaknesses
9.5 Zymo Research
9.5.1 Zymo Research Details
9.5.2 Zymo Research Major Business
9.5.3 Zymo Research Genome-Wide DNA Methylation Analysis Service Product and Services
9.5.4 Zymo Research Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Zymo Research Recent Developments/Updates
9.5.6 Zymo Research Competitive Strengths & Weaknesses
9.6 Hologic Diagenode
9.6.1 Hologic Diagenode Details
9.6.2 Hologic Diagenode Major Business
9.6.3 Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Product and Services
9.6.4 Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Hologic Diagenode Recent Developments/Updates
9.6.6 Hologic Diagenode Competitive Strengths & Weaknesses
9.7 CeGaT GmbH
9.7.1 CeGaT GmbH Details
9.7.2 CeGaT GmbH Major Business
9.7.3 CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Product and Services
9.7.4 CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CeGaT GmbH Recent Developments/Updates
9.7.6 CeGaT GmbH Competitive Strengths & Weaknesses
9.8 Active Motif
9.8.1 Active Motif Details
9.8.2 Active Motif Major Business
9.8.3 Active Motif Genome-Wide DNA Methylation Analysis Service Product and Services
9.8.4 Active Motif Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Active Motif Recent Developments/Updates
9.8.6 Active Motif Competitive Strengths & Weaknesses
9.9 Psomagen, Inc.
9.9.1 Psomagen, Inc. Details
9.9.2 Psomagen, Inc. Major Business
9.9.3 Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.9.4 Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Psomagen, Inc. Recent Developments/Updates
9.9.6 Psomagen, Inc. Competitive Strengths & Weaknesses
9.10 EpiGentek
9.10.1 EpiGentek Details
9.10.2 EpiGentek Major Business
9.10.3 EpiGentek Genome-Wide DNA Methylation Analysis Service Product and Services
9.10.4 EpiGentek Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 EpiGentek Recent Developments/Updates
9.10.6 EpiGentek Competitive Strengths & Weaknesses
9.11 CD Genomics
9.11.1 CD Genomics Details
9.11.2 CD Genomics Major Business
9.11.3 CD Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
9.11.4 CD Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 CD Genomics Recent Developments/Updates
9.11.6 CD Genomics Competitive Strengths & Weaknesses
9.12 LC-Bio
9.12.1 LC-Bio Details
9.12.2 LC-Bio Major Business
9.12.3 LC-Bio Genome-Wide DNA Methylation Analysis Service Product and Services
9.12.4 LC-Bio Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 LC-Bio Recent Developments/Updates
9.12.6 LC-Bio Competitive Strengths & Weaknesses
9.13 Rhelixa, Inc.
9.13.1 Rhelixa, Inc. Details
9.13.2 Rhelixa, Inc. Major Business
9.13.3 Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.13.4 Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Rhelixa, Inc. Recent Developments/Updates
9.13.6 Rhelixa, Inc. Competitive Strengths & Weaknesses
9.14 RIKEN GENESIS Co., Ltd.
9.14.1 RIKEN GENESIS Co., Ltd. Details
9.14.2 RIKEN GENESIS Co., Ltd. Major Business
9.14.3 RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Product and Services
9.14.4 RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 RIKEN GENESIS Co., Ltd. Recent Developments/Updates
9.14.6 RIKEN GENESIS Co., Ltd. Competitive Strengths & Weaknesses
9.15 bitBiome, Inc.
9.15.1 bitBiome, Inc. Details
9.15.2 bitBiome, Inc. Major Business
9.15.3 bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.15.4 bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 bitBiome, Inc. Recent Developments/Updates
9.15.6 bitBiome, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Genome-Wide DNA Methylation Analysis Service Industry Chain
10.2 Genome-Wide DNA Methylation Analysis Service Upstream Analysis
10.3 Genome-Wide DNA Methylation Analysis Service Midstream Analysis
10.4 Genome-Wide DNA Methylation Analysis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Genome-Wide DNA Methylation Analysis Service Introduction
1.2 World Genome-Wide DNA Methylation Analysis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Genome-Wide DNA Methylation Analysis Service Total Market by Region (by Headquarter Location)
1.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.3 China Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.4 Europe Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.5 Japan Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.3.8 India Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome-Wide DNA Methylation Analysis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.2 World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region
2.2.1 World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region (2021-2026)
2.2.2 World Genome-Wide DNA Methylation Analysis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.4 China Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.5 Europe Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.6 Japan Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.7 South Korea Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.8 ASEAN Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
2.9 India Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032)
3 WORLD GENOME-WIDE DNA METHYLATION ANALYSIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Genome-Wide DNA Methylation Analysis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Genome-Wide DNA Methylation Analysis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Genome-Wide DNA Methylation Analysis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Genome-Wide DNA Methylation Analysis Service in 2025
3.3 Genome-Wide DNA Methylation Analysis Service Company Evaluation Quadrant
3.4 Genome-Wide DNA Methylation Analysis Service Market: Overall Company Footprint Analysis
3.4.1 Genome-Wide DNA Methylation Analysis Service Market: Region Footprint
3.4.2 Genome-Wide DNA Methylation Analysis Service Market: Company Product Type Footprint
3.4.3 Genome-Wide DNA Methylation Analysis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison
4.2.1 United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Genome-Wide DNA Methylation Analysis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026)
4.4 China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Genome-Wide DNA Methylation Analysis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026)
4.5 Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole Genome Bisulfite Sequencing (WGBS)
5.2.2 Reduced Representation Bisulfite Sequencing (RRBS)
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2021-2026)
5.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2027-2032)
5.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SAMPLE VARIETY
6.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Sample Variety: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sample Variety
6.2.1 Tissue Samples
6.2.2 Blood & Body Fluid Samples
6.2.3 Cell & Cell Line Samples
6.2.4 Other
6.3 Market Segment by Sample Variety
6.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2021-2026)
6.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2027-2032)
6.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety (2027-2032)
7 MARKET ANALYSIS BY PROJECT SAMPLE NUMBER
7.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Project Sample Number: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Project Sample Number
7.2.1 Small-Scale: ≤10 Samples
7.2.2 Medium-Scale: 11–50 Samples
7.2.3 Large-Scale: 51–200 Samples
7.2.4 High-Throughput: >200 Samples
7.3 Market Segment by Project Sample Number
7.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2021-2026)
7.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2027-2032)
7.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Genome-Wide DNA Methylation Analysis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic and Research Institutions
8.2.2 Pharmaceutical and Biotechnology Companies
8.2.3 Clinical Diagnostics Labs
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2021-2026)
8.3.2 World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2027-2032)
8.3.3 World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences (GENEWIZ)
9.1.1 Azenta Life Sciences (GENEWIZ) Details
9.1.2 Azenta Life Sciences (GENEWIZ) Major Business
9.1.3 Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Product and Services
9.1.4 Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences (GENEWIZ) Recent Developments/Updates
9.1.6 Azenta Life Sciences (GENEWIZ) Competitive Strengths & Weaknesses
9.2 BGI Genomics
9.2.1 BGI Genomics Details
9.2.2 BGI Genomics Major Business
9.2.3 BGI Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
9.2.4 BGI Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BGI Genomics Recent Developments/Updates
9.2.6 BGI Genomics Competitive Strengths & Weaknesses
9.3 Novogene
9.3.1 Novogene Details
9.3.2 Novogene Major Business
9.3.3 Novogene Genome-Wide DNA Methylation Analysis Service Product and Services
9.3.4 Novogene Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Novogene Recent Developments/Updates
9.3.6 Novogene Competitive Strengths & Weaknesses
9.4 Macrogen, Inc.
9.4.1 Macrogen, Inc. Details
9.4.2 Macrogen, Inc. Major Business
9.4.3 Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.4.4 Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Macrogen, Inc. Recent Developments/Updates
9.4.6 Macrogen, Inc. Competitive Strengths & Weaknesses
9.5 Zymo Research
9.5.1 Zymo Research Details
9.5.2 Zymo Research Major Business
9.5.3 Zymo Research Genome-Wide DNA Methylation Analysis Service Product and Services
9.5.4 Zymo Research Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Zymo Research Recent Developments/Updates
9.5.6 Zymo Research Competitive Strengths & Weaknesses
9.6 Hologic Diagenode
9.6.1 Hologic Diagenode Details
9.6.2 Hologic Diagenode Major Business
9.6.3 Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Product and Services
9.6.4 Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Hologic Diagenode Recent Developments/Updates
9.6.6 Hologic Diagenode Competitive Strengths & Weaknesses
9.7 CeGaT GmbH
9.7.1 CeGaT GmbH Details
9.7.2 CeGaT GmbH Major Business
9.7.3 CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Product and Services
9.7.4 CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CeGaT GmbH Recent Developments/Updates
9.7.6 CeGaT GmbH Competitive Strengths & Weaknesses
9.8 Active Motif
9.8.1 Active Motif Details
9.8.2 Active Motif Major Business
9.8.3 Active Motif Genome-Wide DNA Methylation Analysis Service Product and Services
9.8.4 Active Motif Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Active Motif Recent Developments/Updates
9.8.6 Active Motif Competitive Strengths & Weaknesses
9.9 Psomagen, Inc.
9.9.1 Psomagen, Inc. Details
9.9.2 Psomagen, Inc. Major Business
9.9.3 Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.9.4 Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Psomagen, Inc. Recent Developments/Updates
9.9.6 Psomagen, Inc. Competitive Strengths & Weaknesses
9.10 EpiGentek
9.10.1 EpiGentek Details
9.10.2 EpiGentek Major Business
9.10.3 EpiGentek Genome-Wide DNA Methylation Analysis Service Product and Services
9.10.4 EpiGentek Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 EpiGentek Recent Developments/Updates
9.10.6 EpiGentek Competitive Strengths & Weaknesses
9.11 CD Genomics
9.11.1 CD Genomics Details
9.11.2 CD Genomics Major Business
9.11.3 CD Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
9.11.4 CD Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 CD Genomics Recent Developments/Updates
9.11.6 CD Genomics Competitive Strengths & Weaknesses
9.12 LC-Bio
9.12.1 LC-Bio Details
9.12.2 LC-Bio Major Business
9.12.3 LC-Bio Genome-Wide DNA Methylation Analysis Service Product and Services
9.12.4 LC-Bio Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 LC-Bio Recent Developments/Updates
9.12.6 LC-Bio Competitive Strengths & Weaknesses
9.13 Rhelixa, Inc.
9.13.1 Rhelixa, Inc. Details
9.13.2 Rhelixa, Inc. Major Business
9.13.3 Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.13.4 Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Rhelixa, Inc. Recent Developments/Updates
9.13.6 Rhelixa, Inc. Competitive Strengths & Weaknesses
9.14 RIKEN GENESIS Co., Ltd.
9.14.1 RIKEN GENESIS Co., Ltd. Details
9.14.2 RIKEN GENESIS Co., Ltd. Major Business
9.14.3 RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Product and Services
9.14.4 RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 RIKEN GENESIS Co., Ltd. Recent Developments/Updates
9.14.6 RIKEN GENESIS Co., Ltd. Competitive Strengths & Weaknesses
9.15 bitBiome, Inc.
9.15.1 bitBiome, Inc. Details
9.15.2 bitBiome, Inc. Major Business
9.15.3 bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
9.15.4 bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 bitBiome, Inc. Recent Developments/Updates
9.15.6 bitBiome, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Genome-Wide DNA Methylation Analysis Service Industry Chain
10.2 Genome-Wide DNA Methylation Analysis Service Upstream Analysis
10.3 Genome-Wide DNA Methylation Analysis Service Midstream Analysis
10.4 Genome-Wide DNA Methylation Analysis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Genome-Wide DNA Methylation Analysis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Genome-Wide DNA Methylation Analysis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Genome-Wide DNA Methylation Analysis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Genome-Wide DNA Methylation Analysis Service Players in 2025
Table 12. World Genome-Wide DNA Methylation Analysis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Genome-Wide DNA Methylation Analysis Service Company Evaluation Quadrant
Table 14. Head Office of Key Genome-Wide DNA Methylation Analysis Service Players
Table 15. Genome-Wide DNA Methylation Analysis Service Market: Company Product Type Footprint
Table 16. Genome-Wide DNA Methylation Analysis Service Market: Company Product Application Footprint
Table 17. Genome-Wide DNA Methylation Analysis Service Mergers & Acquisitions Activity
Table 18. United States VS China Genome-Wide DNA Methylation Analysis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 23. China Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 29. World Genome-Wide DNA Methylation Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety, (USD Million), 2021 & 2025 & 2032
Table 33. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Sample Variety (2021-2026) & (USD Million)
Table 34. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2027-2032) & (USD Million)
Table 35. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number, (USD Million), 2021 & 2025 & 2032
Table 36. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Project Sample Number (2021-2026) & (USD Million)
Table 37. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2027-2032) & (USD Million)
Table 38. World Genome-Wide DNA Methylation Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences (GENEWIZ) Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences (GENEWIZ) Major Business
Table 43. Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Product and Services
Table 44. Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences (GENEWIZ) Recent Developments/Updates
Table 46. Azenta Life Sciences (GENEWIZ) Competitive Strengths & Weaknesses
Table 47. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 48. BGI Genomics Major Business
Table 49. BGI Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
Table 50. BGI Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BGI Genomics Recent Developments/Updates
Table 52. BGI Genomics Competitive Strengths & Weaknesses
Table 53. Novogene Basic Information, Manufacturing Base and Competitors
Table 54. Novogene Major Business
Table 55. Novogene Genome-Wide DNA Methylation Analysis Service Product and Services
Table 56. Novogene Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novogene Recent Developments/Updates
Table 58. Novogene Competitive Strengths & Weaknesses
Table 59. Macrogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Macrogen, Inc. Major Business
Table 61. Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 62. Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Macrogen, Inc. Recent Developments/Updates
Table 64. Macrogen, Inc. Competitive Strengths & Weaknesses
Table 65. Zymo Research Basic Information, Manufacturing Base and Competitors
Table 66. Zymo Research Major Business
Table 67. Zymo Research Genome-Wide DNA Methylation Analysis Service Product and Services
Table 68. Zymo Research Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Zymo Research Recent Developments/Updates
Table 70. Zymo Research Competitive Strengths & Weaknesses
Table 71. Hologic Diagenode Basic Information, Manufacturing Base and Competitors
Table 72. Hologic Diagenode Major Business
Table 73. Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Product and Services
Table 74. Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Hologic Diagenode Recent Developments/Updates
Table 76. Hologic Diagenode Competitive Strengths & Weaknesses
Table 77. CeGaT GmbH Basic Information, Manufacturing Base and Competitors
Table 78. CeGaT GmbH Major Business
Table 79. CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Product and Services
Table 80. CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CeGaT GmbH Recent Developments/Updates
Table 82. CeGaT GmbH Competitive Strengths & Weaknesses
Table 83. Active Motif Basic Information, Manufacturing Base and Competitors
Table 84. Active Motif Major Business
Table 85. Active Motif Genome-Wide DNA Methylation Analysis Service Product and Services
Table 86. Active Motif Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Active Motif Recent Developments/Updates
Table 88. Active Motif Competitive Strengths & Weaknesses
Table 89. Psomagen, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Psomagen, Inc. Major Business
Table 91. Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 92. Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Psomagen, Inc. Recent Developments/Updates
Table 94. Psomagen, Inc. Competitive Strengths & Weaknesses
Table 95. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 96. EpiGentek Major Business
Table 97. EpiGentek Genome-Wide DNA Methylation Analysis Service Product and Services
Table 98. EpiGentek Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. EpiGentek Recent Developments/Updates
Table 100. EpiGentek Competitive Strengths & Weaknesses
Table 101. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 102. CD Genomics Major Business
Table 103. CD Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
Table 104. CD Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. CD Genomics Recent Developments/Updates
Table 106. CD Genomics Competitive Strengths & Weaknesses
Table 107. LC-Bio Basic Information, Manufacturing Base and Competitors
Table 108. LC-Bio Major Business
Table 109. LC-Bio Genome-Wide DNA Methylation Analysis Service Product and Services
Table 110. LC-Bio Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. LC-Bio Recent Developments/Updates
Table 112. LC-Bio Competitive Strengths & Weaknesses
Table 113. Rhelixa, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Rhelixa, Inc. Major Business
Table 115. Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 116. Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Rhelixa, Inc. Recent Developments/Updates
Table 118. Rhelixa, Inc. Competitive Strengths & Weaknesses
Table 119. RIKEN GENESIS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. RIKEN GENESIS Co., Ltd. Major Business
Table 121. RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 122. RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. RIKEN GENESIS Co., Ltd. Recent Developments/Updates
Table 124. RIKEN GENESIS Co., Ltd. Competitive Strengths & Weaknesses
Table 125. bitBiome, Inc. Basic Information, Manufacturing Base and Competitors
Table 126. bitBiome, Inc. Major Business
Table 127. bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 128. bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. bitBiome, Inc. Recent Developments/Updates
Table 130. bitBiome, Inc. Competitive Strengths & Weaknesses
Table 131. Global Key Players of Genome-Wide DNA Methylation Analysis Service Upstream (Raw Materials)
Table 132. Global Genome-Wide DNA Methylation Analysis Service Typical Customers
Table 1. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Genome-Wide DNA Methylation Analysis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Genome-Wide DNA Methylation Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Genome-Wide DNA Methylation Analysis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Genome-Wide DNA Methylation Analysis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Genome-Wide DNA Methylation Analysis Service Players in 2025
Table 12. World Genome-Wide DNA Methylation Analysis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Genome-Wide DNA Methylation Analysis Service Company Evaluation Quadrant
Table 14. Head Office of Key Genome-Wide DNA Methylation Analysis Service Players
Table 15. Genome-Wide DNA Methylation Analysis Service Market: Company Product Type Footprint
Table 16. Genome-Wide DNA Methylation Analysis Service Market: Company Product Application Footprint
Table 17. Genome-Wide DNA Methylation Analysis Service Mergers & Acquisitions Activity
Table 18. United States VS China Genome-Wide DNA Methylation Analysis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Genome-Wide DNA Methylation Analysis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 23. China Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Genome-Wide DNA Methylation Analysis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Genome-Wide DNA Methylation Analysis Service Revenue Market Share (2021-2026)
Table 29. World Genome-Wide DNA Methylation Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Genome-Wide DNA Methylation Analysis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety, (USD Million), 2021 & 2025 & 2032
Table 33. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Sample Variety (2021-2026) & (USD Million)
Table 34. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety (2027-2032) & (USD Million)
Table 35. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number, (USD Million), 2021 & 2025 & 2032
Table 36. World Genome-Wide DNA Methylation Analysis Service Market Size Value by Project Sample Number (2021-2026) & (USD Million)
Table 37. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number (2027-2032) & (USD Million)
Table 38. World Genome-Wide DNA Methylation Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Genome-Wide DNA Methylation Analysis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences (GENEWIZ) Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences (GENEWIZ) Major Business
Table 43. Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Product and Services
Table 44. Azenta Life Sciences (GENEWIZ) Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences (GENEWIZ) Recent Developments/Updates
Table 46. Azenta Life Sciences (GENEWIZ) Competitive Strengths & Weaknesses
Table 47. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 48. BGI Genomics Major Business
Table 49. BGI Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
Table 50. BGI Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BGI Genomics Recent Developments/Updates
Table 52. BGI Genomics Competitive Strengths & Weaknesses
Table 53. Novogene Basic Information, Manufacturing Base and Competitors
Table 54. Novogene Major Business
Table 55. Novogene Genome-Wide DNA Methylation Analysis Service Product and Services
Table 56. Novogene Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Novogene Recent Developments/Updates
Table 58. Novogene Competitive Strengths & Weaknesses
Table 59. Macrogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Macrogen, Inc. Major Business
Table 61. Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 62. Macrogen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Macrogen, Inc. Recent Developments/Updates
Table 64. Macrogen, Inc. Competitive Strengths & Weaknesses
Table 65. Zymo Research Basic Information, Manufacturing Base and Competitors
Table 66. Zymo Research Major Business
Table 67. Zymo Research Genome-Wide DNA Methylation Analysis Service Product and Services
Table 68. Zymo Research Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Zymo Research Recent Developments/Updates
Table 70. Zymo Research Competitive Strengths & Weaknesses
Table 71. Hologic Diagenode Basic Information, Manufacturing Base and Competitors
Table 72. Hologic Diagenode Major Business
Table 73. Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Product and Services
Table 74. Hologic Diagenode Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Hologic Diagenode Recent Developments/Updates
Table 76. Hologic Diagenode Competitive Strengths & Weaknesses
Table 77. CeGaT GmbH Basic Information, Manufacturing Base and Competitors
Table 78. CeGaT GmbH Major Business
Table 79. CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Product and Services
Table 80. CeGaT GmbH Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CeGaT GmbH Recent Developments/Updates
Table 82. CeGaT GmbH Competitive Strengths & Weaknesses
Table 83. Active Motif Basic Information, Manufacturing Base and Competitors
Table 84. Active Motif Major Business
Table 85. Active Motif Genome-Wide DNA Methylation Analysis Service Product and Services
Table 86. Active Motif Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Active Motif Recent Developments/Updates
Table 88. Active Motif Competitive Strengths & Weaknesses
Table 89. Psomagen, Inc. Basic Information, Manufacturing Base and Competitors
Table 90. Psomagen, Inc. Major Business
Table 91. Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 92. Psomagen, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Psomagen, Inc. Recent Developments/Updates
Table 94. Psomagen, Inc. Competitive Strengths & Weaknesses
Table 95. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 96. EpiGentek Major Business
Table 97. EpiGentek Genome-Wide DNA Methylation Analysis Service Product and Services
Table 98. EpiGentek Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. EpiGentek Recent Developments/Updates
Table 100. EpiGentek Competitive Strengths & Weaknesses
Table 101. CD Genomics Basic Information, Manufacturing Base and Competitors
Table 102. CD Genomics Major Business
Table 103. CD Genomics Genome-Wide DNA Methylation Analysis Service Product and Services
Table 104. CD Genomics Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. CD Genomics Recent Developments/Updates
Table 106. CD Genomics Competitive Strengths & Weaknesses
Table 107. LC-Bio Basic Information, Manufacturing Base and Competitors
Table 108. LC-Bio Major Business
Table 109. LC-Bio Genome-Wide DNA Methylation Analysis Service Product and Services
Table 110. LC-Bio Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. LC-Bio Recent Developments/Updates
Table 112. LC-Bio Competitive Strengths & Weaknesses
Table 113. Rhelixa, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Rhelixa, Inc. Major Business
Table 115. Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 116. Rhelixa, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Rhelixa, Inc. Recent Developments/Updates
Table 118. Rhelixa, Inc. Competitive Strengths & Weaknesses
Table 119. RIKEN GENESIS Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 120. RIKEN GENESIS Co., Ltd. Major Business
Table 121. RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 122. RIKEN GENESIS Co., Ltd. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. RIKEN GENESIS Co., Ltd. Recent Developments/Updates
Table 124. RIKEN GENESIS Co., Ltd. Competitive Strengths & Weaknesses
Table 125. bitBiome, Inc. Basic Information, Manufacturing Base and Competitors
Table 126. bitBiome, Inc. Major Business
Table 127. bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Product and Services
Table 128. bitBiome, Inc. Genome-Wide DNA Methylation Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. bitBiome, Inc. Recent Developments/Updates
Table 130. bitBiome, Inc. Competitive Strengths & Weaknesses
Table 131. Global Key Players of Genome-Wide DNA Methylation Analysis Service Upstream (Raw Materials)
Table 132. Global Genome-Wide DNA Methylation Analysis Service Typical Customers
LIST OF FIGURES
Figure 1. Genome-Wide DNA Methylation Analysis Service Picture
Figure 2. World Genome-Wide DNA Methylation Analysis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome-Wide DNA Methylation Analysis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 13. Genome-Wide DNA Methylation Analysis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Genome-Wide DNA Methylation Analysis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Genome-Wide DNA Methylation Analysis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Genome-Wide DNA Methylation Analysis Service Markets in 2025
Figure 27. United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Genome-Wide DNA Methylation Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type in 2025
Figure 31. Whole Genome Bisulfite Sequencing (WGBS)
Figure 32. Reduced Representation Bisulfite Sequencing (RRBS)
Figure 33. Other
Figure 34. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type (2021-2032)
Figure 35. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety, (USD Million), 2021 & 2025 & 2032
Figure 36. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety in 2025
Figure 37. Tissue Samples
Figure 38. Blood & Body Fluid Samples
Figure 39. Cell & Cell Line Samples
Figure 40. Other
Figure 41. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety (2021-2032)
Figure 42. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number, (USD Million), 2021 & 2025 & 2032
Figure 43. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number in 2025
Figure 44. Small-Scale: ≤10 Samples
Figure 45. Medium-Scale: 11–50 Samples
Figure 46. Large-Scale: 51–200 Samples
Figure 47. High-Throughput: >200 Samples
Figure 48. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number (2021-2032)
Figure 49. World Genome-Wide DNA Methylation Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application in 2025
Figure 51. Academic and Research Institutions
Figure 52. Pharmaceutical and Biotechnology Companies
Figure 53. Clinical Diagnostics Labs
Figure 54. Others
Figure 55. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application (2021-2032)
Figure 56. Genome-Wide DNA Methylation Analysis Service Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Genome-Wide DNA Methylation Analysis Service Picture
Figure 2. World Genome-Wide DNA Methylation Analysis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome-Wide DNA Methylation Analysis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Genome-Wide DNA Methylation Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Genome-Wide DNA Methylation Analysis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Genome-Wide DNA Methylation Analysis Service Revenue (2021-2032) & (USD Million)
Figure 13. Genome-Wide DNA Methylation Analysis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Genome-Wide DNA Methylation Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Genome-Wide DNA Methylation Analysis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Genome-Wide DNA Methylation Analysis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Genome-Wide DNA Methylation Analysis Service Markets in 2025
Figure 27. United States VS China: Genome-Wide DNA Methylation Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome-Wide DNA Methylation Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Genome-Wide DNA Methylation Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type in 2025
Figure 31. Whole Genome Bisulfite Sequencing (WGBS)
Figure 32. Reduced Representation Bisulfite Sequencing (RRBS)
Figure 33. Other
Figure 34. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Type (2021-2032)
Figure 35. World Genome-Wide DNA Methylation Analysis Service Market Size by Sample Variety, (USD Million), 2021 & 2025 & 2032
Figure 36. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety in 2025
Figure 37. Tissue Samples
Figure 38. Blood & Body Fluid Samples
Figure 39. Cell & Cell Line Samples
Figure 40. Other
Figure 41. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Sample Variety (2021-2032)
Figure 42. World Genome-Wide DNA Methylation Analysis Service Market Size by Project Sample Number, (USD Million), 2021 & 2025 & 2032
Figure 43. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number in 2025
Figure 44. Small-Scale: ≤10 Samples
Figure 45. Medium-Scale: 11–50 Samples
Figure 46. Large-Scale: 51–200 Samples
Figure 47. High-Throughput: >200 Samples
Figure 48. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Project Sample Number (2021-2032)
Figure 49. World Genome-Wide DNA Methylation Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application in 2025
Figure 51. Academic and Research Institutions
Figure 52. Pharmaceutical and Biotechnology Companies
Figure 53. Clinical Diagnostics Labs
Figure 54. Others
Figure 55. World Genome-Wide DNA Methylation Analysis Service Market Size Market Share by Application (2021-2032)
Figure 56. Genome-Wide DNA Methylation Analysis Service Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
